IRCT20230803059015N1尚未招募2 期
Evaluating the theranostic application of Lu177-PSMA in management of refractory thyroid papillary cancer.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients with metastatic radio-iodine refractory papillary thyroid cancer
- •Patients with baseline, WBC>3000, Hb>9, platelete .cont>70000, AST and ALT<5*nl limit and Cr<2*nl limit
排除标准
- •Patients who refused to participate in the study
- •Life-expectancy of <1 month
- •History of other concomittant cancer or other end-stage organ disease
- •Patients with baseline, WBC<3000, Hb<9, platelete .cont<70000, AST and ALT>5*nl limit and Cr>2*nl limit
研究者
相似试验
尚未招募
2 期
Effect of Lu177-dotatate in meningiomaMeningioma.Malignant neoplasm of meninges, unspecifiedC70.9IRCT20190623043986N1Shiraz University of Medical Sciences10
招募中
不适用
Evaluation of the therapeutic efficiency of the placenta mesenchymal stem cell-derived exosomes on the improvement of interstitial lungIRCT20130812014333N184Kermanshah University of Medical Sciences10
尚未招募
Unknown
A study to see if the drug Lu-177 trastuzumab can be used to treat patinets with HER-2 positive cancer breastCTRI/2023/05/053068Ashok Kumar
尚未招募
2 期
A study to evaluate the effectiveness of 177-Lu-DOTA Rituximab drug in adult patients diagnosed with the recurrence of low-grade B-cell lymphomas (a type of blood cancer).CTRI/2021/02/031578Tata Research Administrative Council TRAC
已完成
不适用
Clinical evaluation study of newly developed Luminex-based all RAS mutation assay kitColorectal cancerJPRN-UMIN000011784Medical Biological Laboratories Co.,LTD.300